Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ruben Bacares"'
Autor:
Ryan N. Ptashkin, Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao, Jacklyn Casanova, Yun-Te David Lin, Kseniya Petrova-Drus, Abhinita S. Mohanty, Ruben Bacares, Jamal Benhamida, Satshil Rana, Anna Razumova, Chad Vanderbilt, Anoop Balakrishnan Rema, Ivelise Rijo, Julie Son-Garcia, Ino de Bruijn, Menglei Zhu, Sean Lachhander, Wei Wang, Mohammad S. Haque, Venkatraman E. Seshan, Jiajing Wang, Ying Liu, Khedoudja Nafa, Laetitia Borsu, Yanming Zhang, Umut Aypar, Sarah P. Suehnholz, Debyani Chakravarty, Jae H. Park, Omar Abdel-Wahab, Anthony R. Mato, Wenbin Xiao, Mikhail Roshal, Mariko Yabe, Connie Lee Batlevi, Sergio Giralt, Gilles Salles, Raajit Rampal, Martin Tallman, Eytan M. Stein, Anas Younes, Ross L. Levine, Miguel-Angel Perales, Marcel R. M. van den Brink, Ahmet Dogan, Marc Ladanyi, Michael F. Berger, A. Rose Brannon, Ryma Benayed, Ahmet Zehir, Maria E. Arcila
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Genomic profiling of hematologic malignancies has augmented our understanding of variants that contribute to disease pathogenesis and supported development of prognostic models that inform disease management in the clinic. Tumor only sequenc
Externí odkaz:
https://doaj.org/article/59810dc4afb84879a7847ea6b19a947d
Autor:
Zarina Yelskaya, Ruben Bacares, Erin Salo-Mullen, Joshua Somar, Deborah A Lehrich, Grace-Ann Fasaye, Daniel G Coit, Laura H Tang, Zsofia K Stadler, Liying Zhang
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165654 (2016)
Disease-causing germline mutations in CDH1 cause Hereditary Diffuse Gastric Cancer (HDGC). For patients who meet the HDGC screening criteria, the identification and classification of the sequence variants found in CDH1 are critical for risk managemen
Externí odkaz:
https://doaj.org/article/ee48cff8e51342bcba80629818b5e709
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0119224 (2015)
BAP1 is a tumor suppressor gene that is lost or deleted in diverse cancers, including uveal mela¬noma, malignant pleural mesothelioma (MPM), clear cell renal carcinoma, and cholangiocarcinoma. Recently, BAP1 germline mutations have been reported in
Externí odkaz:
https://doaj.org/article/24f5991596d341538241850c5aa3b618
Autor:
Helen Won, James J. Harding, David S. Klimstra, Andrea Cercek, Nitya Raj, Emmet Jordan, Darren R. Feldman, Michael F. Berger, Barry S. Taylor, Meera Hameed, Jacklyn Casanova, Jesse Galle, Meera Prasad, Sumit Middha, Pedram Razavi, Philip Jonsson, Jaclyn F. Hechtman, Ritika Kundra, David B. Solit, Yelena Y. Janjigian, Jonathan A. Coleman, Lisa Stewart, Antonio Omuro, Stacy B. Thomas, Anoop Balakrishnan Rema, Snjezana Dogan, Preethi Srinivasan, Ryan Ptashkin, Dara S. Ross, Mrinal M. Gounder, Bernard H. Bochner, Dalicia N. Reales, Hikmat Al-Ahmadie, Michael H. Eubank, Hsiao-Wei Chen, Mustafa H Syed, Donavan T. Cheng, Jinjuan Yao, Gowtham Jayakumaran, Ryma Benayed, David M. Hyman, Deborah DeLair, Howard I. Scher, Sean M. Devlin, Justyna Sadowska, Rona Yaeger, Anna M. Varghese, Matthew D. Hellmann, Matthew T. Chang, Zachary J. Heins, José Baselga, Tara Soumerai, Alexander N. Shoushtari, Ahmet Zehir, Alison M. Schram, Debyani Chakravarty, Efsevia Vakiani, Leonard B. Saltz, Maria E. Arcila, Gregory J. Riely, Gopa Iyer, Ruben Bacares, Tessara Baldi, Hyunjae R. Kim, Robert Durany, Sarah Phillips, Maeve A. Lowery, Mark E. Robson, A. Ari Hakimi, Niedzica Camacho, Jiaojiao Wang, Khedoudja Nafa, Hongxin Zhang, Marc Ladanyi, Alexander V Penson, Iwona Kiecka, Aijazuddin Syed, Jianjiong Gao, Jonathan Wills, Raghu Chandramohan, Nikolaus Schultz, Kerry Mullaney, Laetitia Borsu, Diana Mandelker, Julie B Son, Wassim Abida, Ciara Marie Kelly, Benjamin Gross, Adam Abeshouse, Roy Cambria, Luc G. T. Morris, Neerav Shukla, Paul Sabbatini, Zhen Y Liu, Ronak Shah, Anna Razumova, Abhinita Mohanty, Stuart Gardos, David Barron, Angelica Ochoa
Publikováno v:
Nature Medicine. 23:703-713
Tumor molecular profiling is a fundamental component of precision oncology, enabling the identification of genomic alterations in genes and pathways that can be targeted therapeutically. The existence of recurrent targetable alterations across distin
Autor:
Liying Zhang, Jinru Shia, Jiqing Ye, Tushar Samdani, Efsevia Vakiani, Martin R. Weiser, Ruben Bacares, Deborah DeLair, Robert A. Soslow, Yi Zhou, Sinisa Ivelja, David S. Klimstra, Mithat Gonen
Publikováno v:
Human Pathology. 45:2430-2436
AT-rich interactive domain-containing protein 1A (ARID1A), a chromatin remodeling gene recently discovered to be a tumor suppressor in ovarian cancers, has been found to be mutated at low frequencies in many other tumors including colorectal carcinom
Autor:
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin, Matthew D Hellmann, David A Barron, Alison M Schram, Meera Hameed, Snjezana Dogan, Dara S Ross, Jaclyn F Hechtman, Deborah F DeLair, JinJuan Yao, Diana L Mandelker, Donavan T Cheng, Raghu Chandramohan, Abhinita S Mohanty, Ryan N Ptashkin, Gowtham Jayakumaran, Meera Prasad, Mustafa H Syed, Anoop Balakrishnan Rema, Zhen Y Liu, Khedoudja Nafa, Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona J Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry A Mullaney, Hikmat Al-Ahmadie, Efsevia Vakiani, Adam A Abeshouse, Alexander V Penson, Philip Jonsson, Niedzica Camacho, Matthew T Chang, Helen H Won, Benjamin E Gross, Ritika Kundra, Zachary J Heins, Hsiao-Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B Thomas, Stuart M Gardos, Dalicia N Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R Feldman, Mrinal M Gounder, A Ari Hakimi, James J Harding, Gopa Iyer, Yelena Y Janjigian, Emmet J Jordan, Ciara M Kelly, Maeve A Lowery, Luc G T Morris, Antonio M Omuro, Nitya Raj, Pedram Razavi, Alexander N Shoushtari, Neerav Shukla, Tara E Soumerai, Anna M Varghese, Rona Yaeger, Jonathan Coleman, Bernard Bochner, Gregory J Riely, Leonard B Saltz, Howard I Scher, Paul J Sabbatini, Mark E Robson, David S Klimstra, Barry S Taylor, Jose Baselga, Nikolaus Schultz, David M Hyman, Maria E Arcila, David B Solit, Marc Ladanyi, Michael F Berger
Publikováno v:
Nature medicine
Tumor molecular profiling is a fundamental component of precision oncology, enabling the identification of genomic alterations in genes and pathways that can be targeted therapeutically. The existence of recurrent targetable alterations across distin
Autor:
Hangjun Wang, Xiaoling Xiong, Nora Katabi, Min Guo, Efsevia Vakiani, Marc Ladanyi, Laura H. Tang, Ruben Bacares, Moshe Shike, Jinru Shia, Liying Zhang, C. Richard Boland, Jeanine M. Ruggeri, David S. Klimstra, Zsofia K. Stadler
Publikováno v:
Modern Pathology. 26:131-138
Immunohistochemical staining for DNA mismatch repair proteins may be affected by various biological and technical factors. Staining variations that could potentially lead to erroneous interpretations have been recognized. A recently recognized staini
Autor:
Grace-Ann Fasaye, Zsofia K. Stadler, Liying Zhang, Erin E. Salo-Mullen, Laura H. Tang, Zarina Yelskaya, Joshua Somar, Daniel G. Coit, Ruben Bacares, Deborah A. Lehrich
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 11, p e0165654 (2016)
PLoS ONE, Vol 11, Iss 11, p e0165654 (2016)
Disease-causing germline mutations in CDH1 cause Hereditary Diffuse Gastric Cancer (HDGC). For patients who meet the HDGC screening criteria, the identification and classification of the sequence variants found in CDH1 are critical for risk managemen
Autor:
Martin R. Weiser, Kenneth Offit, Liying Zhang, Daniel G. Coit, Zsofia K. Stadler, Derek G. Power, Ruben Bacares, Mark E. Robson, Erin E. Salo-Mullen, Jinru Shia, Mark A. Schattner
Publikováno v:
Journal of Clinical Oncology. 30:e229-e232
Autor:
Lishi Chen, Liying Zhang, Joshua Somar, Yelena Kemel, Jeanine M. Ruggeri, Ruben Bacares, Kenneth Offit, Zsofia K. Stadler
Publikováno v:
Breast Cancer Research and Treatment. 130:1051-1056
Mutation screening of the breast and ovarian cancer predisposition genes BRCA1 and BRCA2 is becoming an increasingly important part of clinical practice. Classification of rare non-truncating sequence variants in the BRCA1 and BRCA2 genes is problema